United States · 
Who invested in Avenzo Therapeutics?
Avenzo Therapeutics's investors include New Enterprise Associates, OrbiMed, SR One, Foresite Capital and Sands Capital Ventures, and 1 more on record.
United States · Series B startup
Who invested in Avenzo Therapeutics
Funding summaryUpdated 26 Oct 2026
$60Mraised across 1 round since 2025, from 1 source
- Latest round
- Series B, $60MSept 2025
- Investors
- 6
The rounds
- Sept 2025Series B$60M
Source recordedSEC filing: $47M sold, first sale Aug 2025
Founders and team
From Avenzo Therapeutics's own website: 5 on the team.
- Aaron HasnainSenior Vice President, Business Development
- Connie WedelChief Human Resources Officer
- Heather SunChief of Staff
- Barbara BodemDirector
- Elizabeth A. MilyDirector
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Avenzo Therapeutics
How much has Avenzo Therapeutics raised?
Avenzo Therapeutics has raised $60M across 1 round since 2025.
When did Avenzo Therapeutics last raise?
Avenzo Therapeutics's most recent round was a Series B of $60M in Sept 2025.
What was Avenzo Therapeutics's biggest round?
Its most recent round, $60M in Sept 2025, is also its largest on record.
Who backed Avenzo Therapeutics first?
Avenzo Therapeutics's first round on record, in Sept 2025, was backed by New Enterprise Associates, OrbiMed and SR One and 3 others.
What stage is Avenzo Therapeutics at?
Avenzo Therapeutics's latest named round is a Series B, in Sept 2025.
Where is Avenzo Therapeutics based?
Avenzo Therapeutics is based in the United States.
Companies like Avenzo Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.